# Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing

> **NCT01456364** · PHASE4 · UNKNOWN · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 70 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01456364
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456364, "Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01456364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*